Cargando…

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review

Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Elian, Viviana, Popovici, Violeta, Ozon, Emma-Adriana, Musuc, Adina Magdalena, Fița, Ancuța Cătălina, Rusu, Emilia, Radulian, Gabriela, Lupuliasa, Dumitru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456000/
https://www.ncbi.nlm.nih.gov/pubmed/37629520
http://dx.doi.org/10.3390/life13081663
_version_ 1785096590081392640
author Elian, Viviana
Popovici, Violeta
Ozon, Emma-Adriana
Musuc, Adina Magdalena
Fița, Ancuța Cătălina
Rusu, Emilia
Radulian, Gabriela
Lupuliasa, Dumitru
author_facet Elian, Viviana
Popovici, Violeta
Ozon, Emma-Adriana
Musuc, Adina Magdalena
Fița, Ancuța Cătălina
Rusu, Emilia
Radulian, Gabriela
Lupuliasa, Dumitru
author_sort Elian, Viviana
collection PubMed
description Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes.
format Online
Article
Text
id pubmed-10456000
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104560002023-08-26 Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review Elian, Viviana Popovici, Violeta Ozon, Emma-Adriana Musuc, Adina Magdalena Fița, Ancuța Cătălina Rusu, Emilia Radulian, Gabriela Lupuliasa, Dumitru Life (Basel) Review Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes. MDPI 2023-07-30 /pmc/articles/PMC10456000/ /pubmed/37629520 http://dx.doi.org/10.3390/life13081663 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Elian, Viviana
Popovici, Violeta
Ozon, Emma-Adriana
Musuc, Adina Magdalena
Fița, Ancuța Cătălina
Rusu, Emilia
Radulian, Gabriela
Lupuliasa, Dumitru
Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
title Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
title_full Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
title_fullStr Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
title_full_unstemmed Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
title_short Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
title_sort current technologies for managing type 1 diabetes mellitus and their impact on quality of life—a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456000/
https://www.ncbi.nlm.nih.gov/pubmed/37629520
http://dx.doi.org/10.3390/life13081663
work_keys_str_mv AT elianviviana currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT popovicivioleta currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT ozonemmaadriana currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT musucadinamagdalena currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT fitaancutacatalina currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT rusuemilia currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT raduliangabriela currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview
AT lupuliasadumitru currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview